tiprankstipranks
Advertisement
Advertisement

AU:AGN Stock Latest News

Argenica Advances ARG-007 Stroke Program and Strengthens Funding for Phase 2b Trial
Company AnnouncementsArgenica Advances ARG-007 Stroke Program and Strengthens Funding for Phase 2b Trial
23d ago
AGN
Argenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug
PremiumCompany Announcements
Argenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug
2M ago
AGN
Argenica Widens Half-Year Loss as ARG-007 Stroke Trial Spending Climbs
PremiumCompany Announcements
Argenica Widens Half-Year Loss as ARG-007 Stroke Trial Spending Climbs
3M ago
AGN
Argenica Wins EMA Paediatric Waiver, Streamlining EU Pathway for Stroke Drug ARG-007
PremiumCompany Announcements
Argenica Wins EMA Paediatric Waiver, Streamlining EU Pathway for Stroke Drug ARG-007
4M ago
AGN
Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
PremiumCompany Announcements
Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
4M ago
AGN
Argenica Therapeutics Announces Departure of Director Di Angus
PremiumCompany AnnouncementsArgenica Therapeutics Announces Departure of Director Di Angus
5M ago
AGN
Argenica Chair Steps Down as Biotech Prepares for Next Growth Phase
Premium
Company Announcements
Argenica Chair Steps Down as Biotech Prepares for Next Growth Phase
5M ago
AGN
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
Premium
Company Announcements
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
5M ago
AGN
Argenica’s ARG-007 Shows Promising Results in Preclinical Stroke Study
PremiumCompany Announcements
Argenica’s ARG-007 Shows Promising Results in Preclinical Stroke Study
6M ago
AGN
Argenica Therapeutics AGM Resolutions Passed Successfully
PremiumCompany Announcements
Argenica Therapeutics AGM Resolutions Passed Successfully
6M ago
AGN
Argenica Therapeutics Advances ARG-007 Amidst Clinical and Market Challenges
PremiumCompany Announcements
Argenica Therapeutics Advances ARG-007 Amidst Clinical and Market Challenges
6M ago
AGN
Argenica Therapeutics Announces Retirement of Key Board Member
PremiumCompany Announcements
Argenica Therapeutics Announces Retirement of Key Board Member
6M ago
AGN
Argenica Therapeutics Advances Stroke Treatment with Promising Trial Results
PremiumCompany AnnouncementsArgenica Therapeutics Advances Stroke Treatment with Promising Trial Results
7M ago
AGN
Argenica Therapeutics Issues New Equity Securities as Part of Employee Incentive Scheme
Premium
Company Announcements
Argenica Therapeutics Issues New Equity Securities as Part of Employee Incentive Scheme
7M ago
AGN
Argenica Therapeutics Reports Positive Phase 2 Trial Results for Stroke Treatment
Premium
Company Announcements
Argenica Therapeutics Reports Positive Phase 2 Trial Results for Stroke Treatment
7M ago
AGN
Argenica Therapeutics Announces Details for Upcoming Annual General Meeting
PremiumCompany Announcements
Argenica Therapeutics Announces Details for Upcoming Annual General Meeting
7M ago
AGN
Argenica Therapeutics Unveils Strategic Presentation at ASX Conference
PremiumCompany Announcements
Argenica Therapeutics Unveils Strategic Presentation at ASX Conference
8M ago
AGN
Argenica Therapeutics Sets Date for Annual General Meeting
PremiumCompany Announcements
Argenica Therapeutics Sets Date for Annual General Meeting
8M ago
AGN
Argenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Results
PremiumCompany Announcements
Argenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Results
9M ago
AGN
Argenica Therapeutics Unveils Phase 2 Trial Results
PremiumCompany AnnouncementsArgenica Therapeutics Unveils Phase 2 Trial Results
9M ago
AGN
Argenica Therapeutics Reports Promising Phase 2 Results for Stroke Treatment ARG-007
Premium
Company Announcements
Argenica Therapeutics Reports Promising Phase 2 Results for Stroke Treatment ARG-007
9M ago
AGN
Argenica Therapeutics Initiates Trading Halt Ahead of Clinical Trial Results
Premium
Company Announcements
Argenica Therapeutics Initiates Trading Halt Ahead of Clinical Trial Results
9M ago
AGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >